MAGNESIUM METALLICUM
Breast
Beni-Suef UniversitySmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
10 Active assets in the Breast cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Olaparib AstraZeneca | Phase 2 | BB |
Vinorelbine Sun Yat-sen University | Phase 2 | BB |
Eloxatin University of Southern California | Phase 2/3 | BB |
Pycnogenol National Center for Complementary and Integrative Health (NCCIH) | Phase 2 | B |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Beni-Suef University | Phase 2 | B |
View all 14 →
Same molecule, other indications
MAGNESIUM METALLICUM is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →